Amryt Pharma (LON:AMYT) Shares Cross Below 50-Day Moving Average of $143.00

Amryt Pharma plc (LON:AMYTGet Rating) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 143 ($1.79) and traded as low as GBX 143 ($1.79). Amryt Pharma shares last traded at GBX 143 ($1.79), with a volume of 90,727 shares trading hands.

Amryt Pharma Price Performance

The firm has a market capitalization of £457.11 million and a price-to-earnings ratio of -4.33. The company has a fifty day moving average price of GBX 143 and a two-hundred day moving average price of GBX 143. The company has a quick ratio of 1.14, a current ratio of 1.80 and a debt-to-equity ratio of 66.05.

Amryt Pharma Company Profile

(Get Rating)

Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.

Further Reading

Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with's FREE daily email newsletter.